Application Highlight
PSI™ Applied to Autoimmune Progression and Precise Therapeutic Targeting

Learn how PSI can help you characterize critical functional subsets of innate immune cells in multiple sclerosis patients to understand novel targets and advance therapy development.

Role of innate immunity in Multiple Sclerosis pathogenesis requires further understanding

See how IsoPlexis’ Polyfunctional Strength Index (PSI) can be used to assess cytokine secretion of single innate immune cells, i.e. monocytes, in autoimmune patients to monitor progression.

Download Resource

Your Data is Secure

We will always keep your personal information safe and not share it with any third parties. By submitting this form, you agree to receive communications from IsoPlexis and accept our Privacy Policy.

You may unsubscribe and update your email subscription at any time.

PSI™ Applied to Autoimmune Progression and Precise Therapeutic Targeting

Learn how PSI can help you characterize critical functional subsets of innate immune cells in multiple sclerosis patients to understand novel targets and advance therapy development. Role of innate immunity in Multiple Sclerosis pathogenesis requires further understanding See how IsoPlexis’ Polyfunctional Strength Index (PSI) can be used to assess cytokine secretion of single innate immune cells, i.e. monocytes, in autoimmune patients to monitor progression.

In this Application Highlight we discuss:
  • Demonstrate the value of PSI to reveal functional heterogeneity of single innate immune cells
  • Show that by detecting highly dysfunctional cell subsets, PSI can lead to the unique detection of key patient differences in autoimmune progression
  • Demonstrate how these differences can reveal critical therapeutic insight and novel targets